Posts Tagged ‘its-fourth-quarter

ARYx Therapeutics Inc.

Biotechnology company Isis Pharmaceuticals Inc. said Monday its fourth-quarter loss widened on a boost in research and development costs.

Biotechnology company Allos Therapeutics Inc. said Monday its fourth-quarter loss widened on higher costs associated with sales of the cancer drug Folotyn.

Development-stage biotechnology company Seattle Genetics Inc. said Tuesday its fourth-quarter loss narrowed on higher revenue from partnerships….

Biotechnology company MannKind Corp.


About Biolexis

Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.

Biotech

    high tech agricultureMicrobiologists icon 3 - Stock illustrationMicrobiologists icon 2 - Stock illustrationMicrobiologists icon 1 - Stock illustrationMicrobiologists icon 4 - Stock illustrationThe Liquid-moving Thingy